2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Lung Neoplasms
26
Prostatic Neoplasms
24
Breast Neoplasms
17
Carcinoma, Non-Small-Cell Lung
15
Multiple Myeloma
14
Sarcoma
12
Leukemia, Myeloid, Acute
12
Glioma
12
Lymphoma, Non-Hodgkin
10
Carcinoma, Hepatocellular
10
Wilms Tumor
9
Osteosarcoma
9
Colorectal Neoplasms
9
Rectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Ovarian Neoplasms
8
Neuroblastoma
8
Neoplasm Metastasis
8
Myelodysplastic Syndromes
8
Rhabdomyosarcoma
7
Rhabdoid Tumor
7
Pancreatic Neoplasms
7
Mouth Neoplasms
7
Medulloblastoma
7
Hepatoblastoma
7
Neuroectodermal Tumors, Primitive, Peripheral
6
Melanoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Head and Neck Neoplasms
6
Interventions
pembrolizumab
7
Radiotherapy
3
Proton Therapy
3
Interleukin-2
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Rosuvastatin Calcium
2
Paclitaxel
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Cetuximab
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
tislelizumab
1
sotorasib
1
peposertib
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
niraparib
1
neotil
1
necitumumab
1
mirdametinib
1
leronlimab
1
lenvatinib
1
atezolizumab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solid Tumor, Adult
×
X-Rays
×
Clear all
NCT05252975
2022-02-23
IMPRESS
Royal Marsden NHS Foundation Trust
Phase NA
Unknown
10 enrolled